Patients in the study with advanced bladder cancer had less risk of cancer progressing or returning when treated with ...

Overall survival at two years was 82.2% in the durvalumab group and 75.2% in the comparator group. Durvalumab (brand name ...

Keck Medicine of USC is conducting a clinical trial that explores using steam as a potential alternative to surgery or ...

Bladder cancer presents through various symptoms, ranging from subtle changes to more noticeable signs. While some symptoms ...

January is firefighter cancer awareness month, and firefighters have a nine percent chance more than the general public to ...

It doesn't get a lot of public attention, but there's a growing concern over Iowa's yearly increase in new cancer cases and the state's rising cancer ...

An AI system developed to predict a patient's response to immunotherapy could help "democratize" access to the pricey drugs ...

The PD-1 receptor, a major immune checkpoint inhibitor whose signaling is the target of multiple blockbuster anticancer drugs, differs functionally between rodents and humans in previously unknown ...

Pfizer's Phase 3 CREST trial results highlight the efficacy of sasanlimab combined with BCG in treating high-risk non-muscle invasive bladder cancer.

From the death of folk music star Peter Yarrow of Peter, Paul and Mary to good news from broadcasting legend Dick Vitale, ...

Pfizer's experimental treatment for a type of bladder cancer significantly improved the time that patients remained free of ...